Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,221,100
  • Shares Outstanding, K 352,077
  • Annual Sales, $ 4,146 M
  • Annual Income, $ -260,000 K
  • EBIT $ 396 M
  • EBITDA $ 808 M
  • 60-Month Beta 0.46
  • Price/Sales 1.72
  • Price/Cash Flow 10.62
  • Price/Book 1.07

Options Overview Details

View History
  • Implied Volatility 46.83% ( -5.12%)
  • Historical Volatility 29.00%
  • IV Percentile 74%
  • IV Rank 43.40%
  • IV High 90.32% on 07/26/24
  • IV Low 13.47% on 05/14/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 1,184
  • Volume Avg (30-Day) 1,030
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 20,991
  • Open Int (30-Day) 16,026

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.24
  • Number of Estimates 7
  • High Estimate 0.27
  • Low Estimate 0.22
  • Prior Year 0.24
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.10 +9.78%
on 10/08/24
21.69 -8.39%
on 10/14/24
+0.87 (+4.58%)
since 10/04/24
3-Month
15.21 +30.64%
on 08/05/24
21.69 -8.39%
on 10/14/24
+3.54 (+21.68%)
since 08/02/24
52-Week
13.16 +50.99%
on 05/02/24
21.69 -8.39%
on 10/14/24
+2.73 (+15.93%)
since 11/03/23

Most Recent Stories

More News
Bausch + Lomb: Q3 Earnings Snapshot

Bausch + Lomb: Q3 Earnings Snapshot

BLCO : 19.87 (-3.12%)
Why Bausch + Lomb Stock Soared by Over 7% on Monday

It was quite a busy and eventful day for the company.

BX : 167.04 (-0.65%)
BLCO : 19.87 (-3.12%)
TPG : 61.79 (-6.29%)
GS : 511.47 (-1.52%)
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

ALC : 92.17 (+0.41%)
BLCO : 19.87 (-3.12%)
BHC : 9.26 (-5.32%)
Here's Why Bausch Health Stock Gained 14.7% in a Week

Shares of Bausch Health, Inc. BHC gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb BLCO. The industry declined 0.6% during this...

KRYS : 170.85 (-3.14%)
FULC : 3.26 (+1.56%)
BLCO : 19.87 (-3.12%)
BHC : 9.26 (-5.32%)
Why Bausch + Lomb Rallied Today

The highly indebted healthcare stock rose on rumors it may be selling itself.

BLCO : 19.87 (-3.12%)
Bausch + Lomb: Q2 Earnings Snapshot

Bausch + Lomb: Q2 Earnings Snapshot

BLCO : 19.87 (-3.12%)
This Bausch Health Companies Unusually Active Option Is a No-Brainer

Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead.

BHC : 9.26 (-5.32%)
BLCO : 19.87 (-3.12%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

OKYO : 1.1600 (-3.33%)
ALC : 92.17 (+0.41%)
BLCO : 19.87 (-3.12%)
JNJ : 158.24 (-1.18%)
RHHBY : 39.4300 (+0.43%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

/PRNewswire/ -- The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome...

OKYO : 1.1600 (-3.33%)
ALC : 92.17 (+0.41%)
BLCO : 19.87 (-3.12%)
JNJ : 158.24 (-1.18%)
RHHBY : 39.4300 (+0.43%)
Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 19.87 (-3.12%)
BLCO.TO : 27.76 (-3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 21.12
2nd Resistance Point 20.80
1st Resistance Point 20.34
Last Price 19.87
1st Support Level 19.56
2nd Support Level 19.24
3rd Support Level 18.78

See More

52-Week High 21.69
Last Price 19.87
Fibonacci 61.8% 18.43
Fibonacci 50% 17.42
Fibonacci 38.2% 16.42
52-Week Low 13.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar